Stock REMEDY REMEDY ENTERTAINMENT OYJ
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Remedy Entertainment Oyj

Equities

REMEDY

FI4000251897

Market Closed - Nasdaq Helsinki
Other stock markets
 11:29:56 2024-05-28 am EDT 		5-day change 1st Jan Change
19.68 EUR +1.76% Intraday chart for Remedy Entertainment Oyj +1.03% -22.52%
May. 08 Terhi Kauppi Resigns as Chief Financial Officer of Remedy Entertainment Plc, Effective June 30, 2024 CI
Apr. 29 Transcript : Remedy Entertainment Oyj, Q1 2024 Earnings Call, Apr 29, 2024

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • The opinion of analysts covering the stock has improved over the past four months.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company has insufficient levels of profitability.
  • With an enterprise value anticipated at 5.2 times the sales for the current fiscal year, the company turns out to be overvalued.
  • The company appears highly valued given the size of its balance sheet.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Software

1st Jan change Capi. Investor Rating ESG Refinitiv
REMEDY ENTERTAINMENT OYJ Stock Remedy Entertainment Oyj
-23.62% 285M -
MICROSOFT CORPORATION Stock Microsoft Corporation
+13.97% 3,197B
C+
SYNOPSYS INC. Stock Synopsys Inc.
+13.31% 89.6B
B
CADENCE DESIGN SYSTEMS, INC. Stock Cadence Design Systems, Inc.
+8.58% 80.08B
B+
DASSAULT SYSTÈMES SE Stock Dassault Systèmes SE
-13.33% 55.52B
B+
PALANTIR TECHNOLOGIES INC. Stock Palantir Technologies Inc.
+22.92% 46.79B
D+
THE TRADE DESK, INC. Stock The Trade Desk, Inc.
+31.75% 46.34B
D+
ATLASSIAN CORPORATION Stock Atlassian Corporation
-29.34% 43.95B
B-
SEA LIMITED Stock Sea Limited
+65.54% 41.34B
D+
TAKE-TWO INTERACTIVE SOFTWARE, INC. Stock Take-Two Interactive Software, Inc.
-3.62% 26.5B
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. REMEDY Stock
  4. Ratings Remedy Entertainment Oyj